1. Home
  2. DMAC vs DOYU Comparison

DMAC vs DOYU Comparison

Compare DMAC & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • DOYU
  • Stock Information
  • Founded
  • DMAC 2000
  • DOYU 2014
  • Country
  • DMAC United States
  • DOYU China
  • Employees
  • DMAC N/A
  • DOYU N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • DOYU Computer Software: Programming Data Processing
  • Sector
  • DMAC Health Care
  • DOYU Technology
  • Exchange
  • DMAC Nasdaq
  • DOYU Nasdaq
  • Market Cap
  • DMAC 274.1M
  • DOYU 312.9M
  • IPO Year
  • DMAC N/A
  • DOYU 2019
  • Fundamental
  • Price
  • DMAC $4.82
  • DOYU $11.50
  • Analyst Decision
  • DMAC Strong Buy
  • DOYU Strong Sell
  • Analyst Count
  • DMAC 3
  • DOYU 3
  • Target Price
  • DMAC $7.00
  • DOYU $7.03
  • AVG Volume (30 Days)
  • DMAC 118.6K
  • DOYU 124.8K
  • Earning Date
  • DMAC 11-13-2024
  • DOYU 11-20-2024
  • Dividend Yield
  • DMAC N/A
  • DOYU N/A
  • EPS Growth
  • DMAC N/A
  • DOYU N/A
  • EPS
  • DMAC N/A
  • DOYU N/A
  • Revenue
  • DMAC N/A
  • DOYU $631,661,209.00
  • Revenue This Year
  • DMAC N/A
  • DOYU N/A
  • Revenue Next Year
  • DMAC N/A
  • DOYU N/A
  • P/E Ratio
  • DMAC N/A
  • DOYU N/A
  • Revenue Growth
  • DMAC N/A
  • DOYU N/A
  • 52 Week Low
  • DMAC $2.14
  • DOYU $6.29
  • 52 Week High
  • DMAC $6.41
  • DOYU $20.17
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 47.28
  • DOYU 52.63
  • Support Level
  • DMAC $5.05
  • DOYU $11.07
  • Resistance Level
  • DMAC $5.74
  • DOYU $12.32
  • Average True Range (ATR)
  • DMAC 0.37
  • DOYU 0.68
  • MACD
  • DMAC -0.08
  • DOYU -0.09
  • Stochastic Oscillator
  • DMAC 28.10
  • DOYU 21.08

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.

Share on Social Networks: